FR2035966B1 - - Google Patents

Info

Publication number
FR2035966B1
FR2035966B1 FR7010930A FR7010930A FR2035966B1 FR 2035966 B1 FR2035966 B1 FR 2035966B1 FR 7010930 A FR7010930 A FR 7010930A FR 7010930 A FR7010930 A FR 7010930A FR 2035966 B1 FR2035966 B1 FR 2035966B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7010930A
Other versions
FR2035966A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BESTIAN WALTER DT
Original Assignee
BESTIAN WALTER DT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1915979A external-priority patent/DE1915979C3/de
Application filed by BESTIAN WALTER DT filed Critical BESTIAN WALTER DT
Publication of FR2035966A1 publication Critical patent/FR2035966A1/fr
Application granted granted Critical
Publication of FR2035966B1 publication Critical patent/FR2035966B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
FR7010930A 1969-03-28 1970-03-26 Expired FR2035966B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1915979A DE1915979C3 (de) 1969-03-20 1969-03-28 1,3-Dimethyl-xanthin-Derivate und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
FR2035966A1 FR2035966A1 (fr) 1970-12-24
FR2035966B1 true FR2035966B1 (fr) 1974-10-11

Family

ID=5729638

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7010930A Expired FR2035966B1 (fr) 1969-03-28 1970-03-26

Country Status (14)

Country Link
US (1) US3734911A (fr)
JP (1) JPS5417757B1 (fr)
AT (2) AT309463B (fr)
BE (1) BE748165A (fr)
BR (1) BR7018080D0 (fr)
CA (1) CA932730A (fr)
CH (1) CH528529A (fr)
DK (1) DK127101B (fr)
ES (1) ES377662A1 (fr)
FR (1) FR2035966B1 (fr)
GB (1) GB1289287A (fr)
NL (1) NL7004161A (fr)
NO (1) NO127618B (fr)
SE (1) SE385893B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374835A (en) * 1980-01-31 1983-02-22 Laroche-Navarron, S.A. Piperazine derivatives of theophylline
IT1195267B (it) * 1980-04-15 1988-10-12 Abc Ist Biolog Chem Spa Derivati teofillinmetildiossolanici,procedimento per la loro preparazione e relative composizioni farmaceutiche
CH648559A5 (de) * 1981-07-20 1985-03-29 Siegfried Ag Theophyllinderivate und verfahren zu deren herstellung.
US4400381A (en) * 1981-07-31 1983-08-23 Laroche-Navarron, S.A. Piperazine derivatives of theophylline
US4374837A (en) * 1981-07-31 1983-02-22 Laroche Navarron, S.A. Piperazine derivatives of theobromine
US4876257A (en) * 1988-03-03 1989-10-24 Ortho Pharmaceutical Corporation 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents
US5021574A (en) * 1988-03-03 1991-06-04 Ortho Pharmaceutical Corporation 6-substituted purinyl piperazine derivatives
US5164390A (en) * 1988-03-03 1992-11-17 Ortho Pharmaceutical Corporation 6-substituted purinyl piperazine derivatives
EP0468065B1 (fr) * 1990-07-23 1994-01-05 Siemens Aktiengesellschaft Aspirateur avec sac à poussières insérable
EP0746557A4 (fr) * 1994-02-18 1997-05-02 Cell Therapeutics Inc Mediateurs de signalisation intracellulaire
US7865927B2 (en) 2006-09-11 2011-01-04 Apple Inc. Enhancing media system metadata

Also Published As

Publication number Publication date
AT317249B (de) 1974-08-26
GB1289287A (fr) 1972-09-13
BR7018080D0 (pt) 1973-04-26
ES377662A1 (es) 1973-01-01
JPS5417757B1 (fr) 1979-07-02
CH528529A (de) 1972-09-30
SE385893B (sv) 1976-07-26
DK127101B (da) 1973-09-24
US3734911A (en) 1973-05-22
BE748165A (fr) 1970-09-28
NL7004161A (fr) 1970-09-30
AT309463B (de) 1973-08-27
CA932730A (en) 1973-08-28
FR2035966A1 (fr) 1970-12-24
NO127618B (fr) 1973-07-23

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU429630B2 (fr)
FR2035966B1 (fr)
AU450150B2 (fr)
AU442375B2 (fr)
AU427401B2 (fr)
AU470301B1 (fr)
AU470661B1 (fr)
AU442538B2 (fr)
AU442322B2 (fr)
AU442380B2 (fr)
AU442285B2 (fr)
AU442535B2 (fr)
AU428131B2 (fr)
AU442357B2 (fr)
AU428129B2 (fr)
AU428074B2 (fr)
AU425297B2 (fr)
AU442554B2 (fr)
AU417208B2 (fr)
AT308690B (fr)
AU438128B2 (fr)
CS148389B1 (fr)
AR203167Q (fr)
AU4540468A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse